China's Biotech Industry

Randomuser

Randomuser

Captain
Registered Member
No wonder a lot of fund managers were stocking up on these this year. There's more to come with a lot of IPOs in places like Hong Kong.

Anyway big players include the following:

Jiangsu Hengrui Pharmaceuticals
Innovent Biologics
Akeso
Hansoh Pharmaceutical
Sichuan Biokin Pharmaceutical
Sichuan Kelun-Biotech Biopharmaceutical
Hansoh Pharmaceutical
BeOne Medicines
WuXi AppTec
WuXi Biologics
 
supercat

supercat

Colonel
Severe Fever with Thrombocytopenia Syndrome (SFTS), also known as tick fever, is a relatively new infectious disease that can potentially cause multi-organ failure and result in a fatality rate of up to 30%. It is caused by a tick-borne virus and is transmitted through tick-bites. SFTS mainly occur in central China with some cases reported in Korea and Japan. It was first discovered in 2009. Until recently, there was no specific treatment. Now, Chinese researchers have developed a potential cure.

Chinese scientists develop broad-spectrum nanobodies for tick fever treatment​

Click to expand...
Please, Log in or Register to view URLs content!

A rationally designed cocktail of nanobodies elicited by heterologous vaccination confers protection against SFTSV in preclinical models​

Click to expand...
Please, Log in or Register to view URLs content!
 
supercat

supercat

Colonel
subotai1 said:
Are there published sources on this and the prices, outside of a X/Twitter post?
Click to expand...
Yes, but it's in Chinese.
https://twitter.com/i/web/status/1996512116057178253
Please, Log in or Register to view URLs content!

Switzerland's Roche Diagnostics starts selling its first China-developed and China-made real-time PCR system, which is used for DNA and RNA analysis.
Please, Log in or Register to view URLs content!

CAR-T therapy is a type of immunotherapy that treat blood cancers, such as certain types of leukemia, lymphoma and multiple myeloma.
Please, Log in or Register to view URLs content!
China's efficient and affordable CAR-T therapy attracts overseas patients.
Please, Log in or Register to view URLs content!

$1.3 billion mutual cancer drug deal:
Kelun-Biotech will grant Crescent Biopharma the exclusive global rights outside China to SKB105, an antibody-drug conjugate targeted cancer therapy, while the US company will license its PD-1/VEGF-targeting tetravalent bispecific antibody to the Chinese partner, the Chengdu-based firm, the holding unit of Kelun Pharmaceutical, said late yesterday.
Click to expand...
Please, Log in or Register to view URLs content!
 
supercat

supercat

Colonel
Nonsensical biotech news of the day:

‘Terrifying’: Why U.S. senator in top intel post wants more spying on Chinese companies​

  • Chinese genomics company BGI has risen to prominence around the world but also has been subject to concerns about its gene sequencing and DNA collection practices.
  • U.S. officials fear BGI’s vast collection of global genomics data is not just intended for precision medicine but a strategic asset that could be used for the Chinese military or surveillance, including the development of a biotech-enabled “super soldier.”
  • Sen. Mark Warner (D-Va.), the top Democrat on the Senate Select Committee on Intelligence, warned at the CNBC CFO Council Summit this week that BGI will become even bigger than the Chinese telecom giant Huawei. “It’s terrifying,” he said.
“If Huawei was big, BGI will be even bigger,” Warner said at the CNBC CFO Council Summit in Washington, D.C. on Wednesday.
Click to expand...
Please, Log in or Register to view URLs content!

Another one goes to China - SCMP headline and video summary below:

Cambridge University ex-vice-chancellor Nigel Slater joins China’s biotech revolution​

Veteran academic to collaborate with Chinese scientists to develop next-gen cancer therapies using vaccine tech for tumour immunotherapy
Click to expand...
 
You must log in or register to reply here.
Top